Patent Yard Sign in
Canadian application, no grantCanada

Use of anti-inflammatory steroids for the treatment of chronic inflammatory intestinal diseases

CA 2290775 A1 · Owner: Meijerink, Johannes Hendriekus · Inventors: Meijerink, Johannes Hendriekus

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The invention relates to the use of inflammatory compounds having general formula (I) wherein X is a member of the group consisting of H and halogen; Y is a member of the group consisting of H2 H(OH), H(O(C1-6)Acyl) and O; R1 is , a member of the group consisting of H CH3 and halogen; R2 is (C1-4)Alkyl; R3 is a member of the group consisting of H O((C1-6)Acyl), O((C1-6)Alkyl) and , CH3; R4 is a member of the group consisting of H and (C1-4)Alkyl and C1-C2 , and C6-C7 are saturated or unsaturated bonds for the manufacture of a , medicament for chronic inflammatory colon diseases.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 2, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 2, 2018.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 2, 2020.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 2, 1998
GrantedNo grant recorded
Term endedJune 2, 2018
Patent numberCA 2290775 A1
Classification (IPC)A61K31/57

Timeline

Timeline From CIPO dates

1999200120032005200720092011201320152017Application filedJune 2, 1998Term endedJune 2, 2018

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.